Cargando…

The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases

In vivo exploration of neurodegenerative diseases by positron emission tomography (PET) imaging has matured over the last 20 years, using dedicated radiopharmaceuticals targeting cellular metabolism, neurotransmission, neuroinflammation, or abnormal protein aggregates (beta-amyloid and intracellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dupont, Anne-Claire, Largeau, Bérenger, Guilloteau, Denis, Santiago Ribeiro, Maria Joao, Arlicot, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985069/ https://www.ncbi.nlm.nih.gov/pubmed/29887768 http://dx.doi.org/10.1155/2018/7043578

Ejemplares similares

Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
por: Dupont, Anne-Claire, et al.
Publicado: (2017)

TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?
por: Largeau, Bérenger, et al.
Publicado: (2017)

Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations
por: Tronel, Claire, et al.
Publicado: (2017)

Could (18) F-DPA-714 PET imaging be interesting to use in the early post-stroke period?
por: Ribeiro, Maria-Joao, et al.
Publicado: (2014)

The Story of the Dopamine Transporter PET Tracer LBT-999: From Conception to Clinical Use
por: Chalon, Sylvie, et al.
Publicado: (2019)

[18F]FDDNP performed better than [18F] Florbetapir to distinguish transthyretin cardiac amyloidosis (TTR-CA) patients from healthy controls: an ex vivo study
por: Dupont, Anne-Claire, et al.
Publicado: (2015)

Usefulness of PET With [(18)F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment
por: Ribeiro, Maria-Joao, et al.
Publicado: (2020)

Fully automated radiosynthesis of [(18)F]LBT999 on TRACERlab FX(FN) and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain
por: Vala, Christine, et al.
Publicado: (2020)

Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks
por: Dupont, Anne-Claire, et al.
Publicado: (2023)

Study of influence of the glutamatergic concentration of [(18)F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers
por: Dupont, Anne-Claire, et al.
Publicado: (2021)

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology
por: Barbet, Jacques, et al.
Publicado: (2017)

Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [(18)F] PET tracer
por: Elie, Jonathan, et al.
Publicado: (2018)

Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience
por: Beaurain, Marie, et al.
Publicado: (2019)

Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
por: Corcia, Philippe, et al.
Publicado: (2012)

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease()
por: Vandenberghe, Rik, et al.
Publicado: (2013)

Interest of FDG-PET in the Management of Mantle Cell Lymphoma
por: Bailly, Clément, et al.
Publicado: (2019)

Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases
por: Bi, Mingxia, et al.
Publicado: (2023)

Pazopanib-induced posterior reversible encephalopathy syndrome with possible syndrome of inappropriate secretion of antidiuretic hormone: an incidental or pathophysiological association?
por: Wong So, Jonathan, et al.
Publicado: (2019)

Posterior Reversible Encephalopathy Syndrome in Clinical Toxicology: A Systematic Review of Published Case Reports
por: Largeau, Bérenger, et al.
Publicado: (2020)

Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases
por: Tago, Tetsuro, et al.
Publicado: (2018)

Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in vitro and Preclinical Imaging Studies
por: Dagallier, Caroline, et al.
Publicado: (2021)

PET and the multitracer concept in the study of neurodegenerative diseases
por: Engler, Henry, et al.
Publicado: (2015)

Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)
por: Yrondi, Antoine, et al.
Publicado: (2018)

Gliosis and Neurodegenerative Diseases: The Role of PET and MR Imaging
por: Cavaliere, Carlo, et al.
Publicado: (2020)

Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases
por: de Souza, Jessica M., et al.
Publicado: (2018)

Polyoxidovanadates a new therapeutic alternative for neurodegenerative and aging diseases
por: Gonzalez-Cano, Sonia Irais, et al.
Publicado: (2023)

Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
por: Magalhães, João Duarte, et al.
Publicado: (2021)

[(11)C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET)
por: Gourand, Fabienne, et al.
Publicado: (2015)

Multitarget Therapeutics for Neurodegenerative Diseases
por: Gabr, Moustafa T., et al.
Publicado: (2020)

Editorial: Glial and Neural Stem Cells as New Therapeutic Targets for Neurodegenerative Disorders
por: Xapelli, Sara, et al.
Publicado: (2020)

Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases
por: Maneu, Victoria, et al.
Publicado: (2021)

Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer
por: Bailly, Matthieu, et al.
Publicado: (2015)

PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases
por: Ghadery, Christine, et al.
Publicado: (2019)

Tau PET imaging in neurodegenerative tauopathies—still a challenge
por: Leuzy, Antoine, et al.
Publicado: (2019)

Detection of Neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [(18)F]DPA-714 PET Imaging
por: Thomas, Clément, et al.
Publicado: (2016)

Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia
por: Ricci, Maria, et al.
Publicado: (2020)

The Therapeutic Potential of Metformin in Neurodegenerative Diseases
por: Rotermund, Carola, et al.
Publicado: (2018)

Therapeutic implication of autophagy in neurodegenerative diseases
por: Rahman, Md. Ataur, et al.
Publicado: (2017)

Fenamates as Potential Therapeutics for Neurodegenerative Disorders
por: Hill, Jaunetta, et al.
Publicado: (2021)

Antioxidant Therapeutic Strategies in Neurodegenerative Diseases
por: Morén, Constanza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ekrnskmhekt0cb3urp6kep7qm9